These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 31420350)
1. Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial. Locatelli F; Hannedouche T; Fishbane S; Morgan Z; Oguey D; White WB Clin J Am Soc Nephrol; 2019 Dec; 14(12):1701-1710. PubMed ID: 31420350 [TBL] [Abstract][Full Text] [Related]
2. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Palmer SC; Saglimbene V; Mavridis D; Salanti G; Craig JC; Tonelli M; Wiebe N; Strippoli GF Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010590. PubMed ID: 25486075 [TBL] [Abstract][Full Text] [Related]
3. Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease. Saglimbene VM; Palmer SC; Ruospo M; Natale P; Craig JC; Strippoli GF Cochrane Database Syst Rev; 2017 Aug; 8(8):CD009904. PubMed ID: 28782299 [TBL] [Abstract][Full Text] [Related]
4. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Chung EY; Palmer SC; Saglimbene VM; Craig JC; Tonelli M; Strippoli GF Cochrane Database Syst Rev; 2023 Feb; 2(2):CD010590. PubMed ID: 36791280 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Long-Term Safety of C.E.R.A. Maintenance in Pediatric Hemodialysis Patients with Anemia of CKD. Fischbach M; Wühl E; Reigner SCM; Morgan Z; Schaefer F Clin J Am Soc Nephrol; 2018 Jan; 13(1):81-90. PubMed ID: 29097481 [TBL] [Abstract][Full Text] [Related]
8. Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial. Carrera F; Lok CE; de Francisco A; Locatelli F; Mann JF; Canaud B; Kerr PG; Macdougall IC; Besarab A; Villa G; Kazes I; Van Vlem B; Jolly S; Beyer U; Dougherty FC; Nephrol Dial Transplant; 2010 Dec; 25(12):4009-17. PubMed ID: 20522670 [TBL] [Abstract][Full Text] [Related]
9. Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients. Piotr B; Mariusz S; Jacek R Curr Pharm Biotechnol; 2017; 18(4):303-308. PubMed ID: 28137221 [TBL] [Abstract][Full Text] [Related]
10. Subcutaneous C.E.R.A. for the Maintenance Treatment of Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study. Warady BA; Meyer Reigner S; Tirodkar C; Drozdz D Am J Kidney Dis; 2023 Jun; 81(6):684-694.e1. PubMed ID: 36587890 [TBL] [Abstract][Full Text] [Related]
11. Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease. Curran MP; McCormack PL Drugs; 2008; 68(8):1139-56. PubMed ID: 18484803 [TBL] [Abstract][Full Text] [Related]
12. Methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa for anemia in non-dialysis-dependent CKD: a systematic review. Alsalimy N; Awaisu A Int J Clin Pharm; 2014 Dec; 36(6):1115-25. PubMed ID: 25288147 [TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety in ESA biosimilars vs. originators in adults with chronic kidney disease: a systematic review and meta-analysis. Amato L; Addis A; Saulle R; Trotta F; Mitrova Z; Davoli M J Nephrol; 2018 Jun; 31(3):321-332. PubMed ID: 28646375 [TBL] [Abstract][Full Text] [Related]
15. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715 [TBL] [Abstract][Full Text] [Related]